Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial

Stopped In light of the evolving Covid19 pandemic ongoing study recruitment was felt to pose an unacceptable risk to patient safety.

Conditions

• COPD
• EBV

Interventions

• DRUG: Valaciclovir
• DRUG: Placebo capsules (containing Avicel blend)

Sponsor

Belfast Health and Social Care Trust

Collaborators

• [object Object]
• [object Object]